Navidea Biopharmaceuticals Debt to Equity Ratio 2006-2019 | NAVB

Current and historical debt to equity ratio values for Navidea Biopharmaceuticals (NAVB) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Navidea Biopharmaceuticals debt/equity for the three months ending September 30, 2019 was 0.21.
Navidea Biopharmaceuticals Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-09-30 $0.00B $0.00B -6.20
2019-06-30 $0.00B $0.00B 0.21
2019-03-31 $0.00B $0.00B 7.24
2018-12-31 $0.00B $0.00B 0.00
2018-09-30 $0.00B $0.00B 0.00
2018-06-30 $0.00B $0.00B 0.00
2018-03-31 $0.00B $0.01B 0.00
2017-12-31 $0.00B $0.01B 0.00
2017-09-30 $0.00B $0.02B 0.00
2017-06-30 $0.00B $0.02B 0.00
2017-03-31 $0.00B $0.02B 0.00
2016-12-31 $0.01B $-0.07B -0.14
2016-09-30 $0.01B $-0.06B -0.17
2016-06-30 $0.01B $-0.06B -0.15
2016-03-31 $0.01B $-0.06B -0.19
2015-12-31 $0.06B $-0.05B -1.13
2015-09-30 $0.06B $-0.43B -0.14
2015-06-30 $0.06B $-0.05B -1.32
2015-03-31 $0.03B $-0.04B -0.83
2014-12-31 $0.03B $-0.03B -0.99
2014-09-30 $0.03B $-0.03B -0.95
2014-06-30 $0.00B $-0.02B 0.00
2014-03-31 $0.03B $-0.02B -2.12
2013-12-31 $0.02B $-0.00B -5.88
2013-09-30 $0.03B $0.01B 2.94
2013-06-30 $0.03B $-0.00B -14.86
2013-03-31 $0.01B $-0.00B -3.77
2012-12-31 $0.01B $-0.00B -4.93
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.01B 0.43
2012-03-31 $0.00B $0.02B 0.00
2011-12-31 $0.01B $0.02B 0.31
2011-09-30 $0.00B $0.03B 0.00
2011-06-30 $0.00B $0.01B 0.00
2011-03-31 $0.00B $0.01B 0.00
2010-12-31 $0.00B $0.00B 0.00
2010-09-30 $0.00B $0.00B 0.01
2010-06-30 $0.00B $0.00B 0.01
2010-03-31 $0.00B $-0.01B -0.09
2009-12-31 $0.00B $-0.01B 0.00
2009-09-30 $0.00B $-0.01B -0.09
2009-06-30 $0.00B $-0.03B -0.03
2009-03-31 $0.00B $-0.02B -0.06
2008-12-31 $0.00B $-0.00B -0.31
2008-09-30 $0.00B $-0.00B -0.54
2008-06-30 $0.00B $0.00B -8.83
2008-03-31 $0.00B $-0.00B -0.49
2007-12-31 $0.00B $-0.00B -0.23
2007-09-30 $0.00B $-0.00B -0.05
2007-06-30 $0.00B $-0.00B -0.05
2007-03-31 $0.00B $-0.00B -0.07
2006-12-31 $0.00B $0.00B -0.33
2006-09-30 $0.00B $0.00B 0.13
2006-06-30 $0.00B $0.00B 0.04
2006-03-31 $0.00B $0.00B 0.03
2005-12-31 $0.00B $0.00B 0.03
2005-09-30 $0.00B $0.01B 0.02
2005-06-30 $0.00B $0.01B 0.02
2005-03-31 $0.00B $0.01B 0.01
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.025B $0.001B
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $133.803B 27.71
Intuitive Surgical (ISRG) United States $68.096B 51.01
Edwards Lifesciences (EW) United States $48.065B 43.65
IDEXX Laboratories (IDXX) United States $24.085B 58.25
Fresenius Medical Care AG KGaA (FMS) Germany $23.905B 16.18
Olympus (OCPNY) Japan $22.142B 0.00
DexCom (DXCM) United States $21.412B 191.75
Teleflex (TFX) United States $17.593B 35.72
SONOVA HOLDING (SONVY) Switzerland $16.068B 0.00
Sysmex ADR (SSMXY) Japan $15.055B 40.53
Hologic (HOLX) United States $14.189B 22.02
Varian Medical Systems (VAR) United States $13.481B 31.96
STERIS (STE) Ireland $12.827B 28.33
Masimo (MASI) United States $9.018B 53.85
ABIOMED (ABMD) United States $8.262B 44.96
SARTORIUS AG (SARTF) Germany $7.903B 69.37
Penumbra (PEN) United States $5.997B 195.17
Globus Medical (GMED) United States $5.235B 32.31
Integra LifeSciences Holdings (IART) United States $4.741B 20.37
Elekta AB (EKTAY) Sweden $4.519B 38.16
Tandem Diabetes Care (TNDM) United States $4.083B 0.00
Nevro (NVRO) United States $3.871B 0.00
Wright Medical Group (WMGI) Netherlands $3.848B 233.23
LivaNova (LIVN) United Kingdom $3.439B 24.76
Integer Holdings (ITGR) United States $2.915B 19.95
Cantel Medical (CMD) United States $2.874B 28.12
Nihon Kohden (NHNKY) Japan $2.475B 24.90
Glaukos (GKOS) United States $2.099B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.435B 28.25
Veracyte (VCYT) United States $1.343B 0.00
Silk Road Medical (SILK) United States $1.320B 0.00
Mesa Laboratories (MLAB) United States $1.157B 42.88
CryoLife (CRY) United States $1.124B 115.31
Natus Medical (NTUS) United States $1.106B 26.59
Tactile Systems Technology (TCMD) United States $1.087B 124.15
OPKO Health (OPK) United States $1.052B 0.00
Inogen (INGN) United States $1.028B 32.47
Luminex (LMNX) United States $1.014B 0.00
Accelerate Diagnostics (AXDX) United States $0.897B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.857B 28.48
OrthoPediatrics (KIDS) United States $0.797B 0.00
Intersect ENT (XENT) United States $0.781B 0.00
Pacific Biosciences Of California (PACB) United States $0.757B 0.00
Quotient (QTNT) Switzerland $0.654B 0.00
Si-Bone (SIBN) United States $0.547B 0.00
AngioDynamics (ANGO) United States $0.544B 24.95
AxoGen (AXGN) United States $0.483B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.440B 13.32
Alphatec Holdings (ATEC) United States $0.390B 0.00
Accuray (ARAY) United States $0.350B 0.00
Sientra (SIEN) United States $0.334B 0.00
Semler Scientific (SMLR) United States $0.327B 45.47
RTI Surgical (RTIX) United States $0.322B 87.20
ViewRay (VRAY) United States $0.315B 0.00
GenMark Diagnostics (GNMK) United States $0.310B 0.00
IRadimed (IRMD) United States $0.296B 41.63
SeaSpine Holdings (SPNE) United States $0.283B 0.00
Fluidigm (FLDM) United States $0.275B 0.00
Restoration Robotics (VERO) Canada $0.168B 0.00
Spectral Diagnostics (EDTXF) Canada $0.128B 0.00
EDAP TMS S.A (EDAP) France $0.122B 32.23
Vermillion (VRML) United States $0.079B 0.00
Neuronetics (STIM) United States $0.078B 0.00
ConforMIS (CFMS) United States $0.070B 0.00
Sensus Healthcare (SRTS) United States $0.070B 0.00
Second Sight Medical Products (EYES) United States $0.067B 0.00
Apollo Endosurgery (APEN) United States $0.061B 0.00
T2 Biosystems (TTOO) United States $0.055B 0.00
Bioanalytical Systems (BASI) United States $0.053B 0.00
Helius Medical Technologies (HSDT) United States $0.039B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.036B 0.00
Neovasc (NVCN) Canada $0.032B 0.00
Ekso Bionics Holdings (EKSO) United States $0.028B 0.00
Ra Medical Systems (RMED) United States $0.026B 0.00
Lianluo Smart (LLIT) China $0.019B 0.00
DarioHealth (DRIO) Israel $0.017B 0.00
ReWalk Robotics (RWLK) Israel $0.015B 0.00
OBALON THERPTCS (OBLN) United States $0.014B 0.00
ENDRA Life Sciences (NDRA) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Allied Healthcare Products (AHPI) United States $0.012B 0.00
Avinger (AVGR) United States $0.010B 0.00
Dynatronics (DYNT) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Viveve Medical (VIVE) United States $0.002B 0.00